Skip to main content
T-Therapeutics  I  About

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge

The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.

We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.

We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanised TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs. These TCRs are directed at multiple target classes, many of which have never been worked on before.

T-Therapeutics is developing a pipeline of first-in-class drugs that will become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.

Investors

Meet the Team

Leadership Team

Prof. Allan Bradley
FRS, FMedSci

Founder and Chief Executive Officer

Read Biography

E-Chiang Lee

Executive Vice President of Research

Read Biography

Hilary van der Hoff

Vice President of IP

Read Biography

Ruud De Wildt

Vice President of Pipeline

Read Biography

Christopher Herring

Vice President of Biology & Safety

Read Biography

Alison Lloyd

Head of Finance

Read Biography

Ruben Cabanillas

Senior Director of Translational Medicine

Read Biography

Board of Directors

Graziano Seghezzi

Chairman

Read Biography

Prof. Allan Bradley
FRS, FMedSci

Founder and Board Director

Read Biography

Samuel Bjork

Board Director

Read Biography

Laia Crespo

Board Observer

Read Biography

Anta Gkelou

Board Observer

Read Biography

Nihal Sinha

Board Director

Read Biography

Anastasiya Sybirna

Board Observer

Read Biography

Robert Tansley

Board Director

Read Biography
Why T-Therapeutics

We are an ambitious organisation with a strong heritage and commitment to world-leading scientific excellence.

Careers

T-Therapeutics is at the forefront of cutting-edge innovation in the field of T cell receptor-based medicines designed to leverage the power of T cells for therapeutic benefit.

We are an ambitious  organisation with a strong heritage and commitment to world-leading scientific excellence. Our employees thrive within an intellectually rich culture of creativity and collaboration, sparking the innovative spirit and creative genius that drive us forward.

If you’re inspired by groundbreaking science, teamwork, and the opportunity to make a real difference for patients with life-threatening conditions, please get in contact with us.

Interested in joining our team?

Please send your CV along with a cover letter to jobs@t-therapeutics.com
T-Therapeutics is an Equal Opportunity employer.
We will consider all applicants without discrimination on grounds of disability, sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law. The ability to perform the job will be the primary consideration.

Pioneering precision medicine, we seamlessly bridge lab breakthroughs to clinical success, unlocking the immune system’s potential for personalised cancer and autoimmune solutions.

Dr. Ruben Cabanillas MD, PhD

Senior Director of Translational Medicine
T-Therapeutics
Suite 1
Riverside 3
Granta Park
Cambridge
CB21 6AD